Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. Domainex will be exhibiting at this event and Dr Cat Stace (Director of Business Development) will be attending.